206 related articles for article (PubMed ID: 10647878)
1. Second malignancies after Hodgkin's disease: the Munich experience.
Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease: study of treatment intensities and incidences of second malignancies.
Rodriguez MA; Fuller LM; Zimmerman SO; Allen PK; Brown BW; Munsell MF; Hagemeister FB; McLaughlin P; Velasquez WS; Swan F
Ann Oncol; 1993 Feb; 4(2):125-31. PubMed ID: 8448080
[TBL] [Abstract][Full Text] [Related]
4. Incidence of second cancers in patients treated for Hodgkin's disease.
Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
[TBL] [Abstract][Full Text] [Related]
5. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
[TBL] [Abstract][Full Text] [Related]
6. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of second cancers in managing Hodgkins disease: the 20-year Leiden experience.
Sont JK; van Stiphout WA; Noordijk EM; Molenaar J; Zwetsloot-Schonk JH; Willemze R; Vandenbroucke JP
Ann Hematol; 1992 Nov; 65(5):213-8. PubMed ID: 1457578
[TBL] [Abstract][Full Text] [Related]
8. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time.
Foss Abrahamsen A; Andersen A; Nome O; Jacobsen AB; Holte H; Foss Abrahamsen J; Kvaløy S
Ann Oncol; 2002 Nov; 13(11):1786-91. PubMed ID: 12419752
[TBL] [Abstract][Full Text] [Related]
9. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract][Full Text] [Related]
10. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
[TBL] [Abstract][Full Text] [Related]
11. [Second malignancies after the therapy of Hodgkin's disease: the Freiburg collective 1940 to 1991].
Slanina J; Heinemann F; Henne K; Moog G; Frommhold H
Strahlenther Onkol; 1999 Apr; 175(4):154-61. PubMed ID: 10230457
[TBL] [Abstract][Full Text] [Related]
12. Second cancers following pediatric Hodgkin's disease.
Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
[TBL] [Abstract][Full Text] [Related]
13. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
Dietrich PY; Henry-Amar M; Cosset JM; Bodis S; Bosq J; Hayat M
Blood; 1994 Aug; 84(4):1209-15. PubMed ID: 8049435
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
15. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
16. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Abrahamsen AF; Kvaløy S; Høst H
J Clin Oncol; 1993 Feb; 11(2):255-61. PubMed ID: 8426202
[TBL] [Abstract][Full Text] [Related]
17. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
Metayer C; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; Joensuu T; van Leeuwen FE; van't Veer MB; Curtis RE; Holowaty EJ; Andersson M; Wiklund T; Gospodarowicz M; Travis LB
J Clin Oncol; 2000 Jun; 18(12):2435-43. PubMed ID: 10856104
[TBL] [Abstract][Full Text] [Related]
18. Second malignancies after treatment for Hodgkin's disease.
Várady E; Deák B; Molnár ZS; Rosta A; Schneider T; Esik O; Eckhardt S
Leuk Lymphoma; 2001; 42(6):1275-81. PubMed ID: 11911408
[TBL] [Abstract][Full Text] [Related]
19. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
[TBL] [Abstract][Full Text] [Related]
20. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
Schellong G; Riepenhausen M
Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
